Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 19-norandrostenololylaurate
2. Laurabolin Vet
1. 26490-31-3
2. Nandrolone Dodecanoate
3. Laurabolin V
4. Wvj22ffn83
5. Unii-wvj22ffn83
6. 19-norandrostenololylaurate
7. 3-oxo-4-estren-17beta-laurat
8. Einecs 247-739-7
9. Laurabolin
10. Laurabolin [veterinary] (tn)
11. Schembl3850364
12. Dtxsid80949362
13. Nandrolone Dodecanoate [mi]
14. Zinc8214710
15. Nandrolone 17.beta.-dodecanoate
16. [(8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl] Dodecanoate
17. 19-nortestosterone 17.beta.-laurate
18. D08251
19. 3-oxoestr-4-en-17.beta.-yl Dodecanoate
20. 490n313
21. Nandrolone Decanoate Impurity I [ep Impurity]
22. Q27292917
23. (8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl Dodecanoate
Molecular Weight | 456.7 g/mol |
---|---|
Molecular Formula | C30H48O3 |
XLogP3 | 8.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 12 |
Exact Mass | 456.36034539 g/mol |
Monoisotopic Mass | 456.36034539 g/mol |
Topological Polar Surface Area | 43.4 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 709 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Nandrolone Laurate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nandrolone Laurate, including repackagers and relabelers. The FDA regulates Nandrolone Laurate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nandrolone Laurate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nandrolone Laurate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nandrolone Laurate supplier is an individual or a company that provides Nandrolone Laurate active pharmaceutical ingredient (API) or Nandrolone Laurate finished formulations upon request. The Nandrolone Laurate suppliers may include Nandrolone Laurate API manufacturers, exporters, distributors and traders.
click here to find a list of Nandrolone Laurate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Nandrolone Laurate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nandrolone Laurate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nandrolone Laurate GMP manufacturer or Nandrolone Laurate GMP API supplier for your needs.
A Nandrolone Laurate CoA (Certificate of Analysis) is a formal document that attests to Nandrolone Laurate's compliance with Nandrolone Laurate specifications and serves as a tool for batch-level quality control.
Nandrolone Laurate CoA mostly includes findings from lab analyses of a specific batch. For each Nandrolone Laurate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nandrolone Laurate may be tested according to a variety of international standards, such as European Pharmacopoeia (Nandrolone Laurate EP), Nandrolone Laurate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nandrolone Laurate USP).
LOOKING FOR A SUPPLIER?